SW
Short Wave
Without this pill, lots of people would be dead
0:00-14:27
25 years ago, the FDA approved a pill that would change the way scientists treat cancer … for good. The pill was called Gleevec; it was designed specifically to treat CML, chronic myeloid leukemia, and it was one of the first targeted cancer therapies available. A quarter century after approval, it’s still being prescribed, as are second, third and fourth-generation drugs that followed in its footsteps. What made it so special – and so effective? Pharmaceutical correspondent Sydney Lupkin walks
Publisher
Short Wave
Published
May 11, 2026
Duration
14 min
Format
Podcast
Category
News · Daily News
Source
RSS feed
SW
Short Wave
@shortwavenpr
#pill #lots #dead
